Valsartan lawsuits have been brought against numerous manufacturers of the blood pressure medication after it was discovered that many batches of the drug sold between 2015 and 2018 were contaminated with potentially carcinogenic impurities. This article explains the details of Valsartan lawsuits, who may be eligible to file claims, potential compensation, and the current litigation status.
What Is Valsartan?
Valsartan is a prescription medication known as an angiotensin-II receptor blocker (ARB). It works by relaxing blood vessels, lowering blood pressure, and improving oxygen and blood supply to the heart. This medication is widely prescribed to manage chronic high blood pressure (hypertension), which can reduce the risk of heart attacks and strokes.
Initially manufactured by Novartis under the brand Diovan in 1996, Valsartan became widely available as a generic drug after Novartis’ patent expired in 2012. Many generic manufacturers sourced Valsartan’s active pharmaceutical ingredient (API) from Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP), a large Chinese pharmaceutical company.
Discovery of Contaminated Valsartan
In June 2018, ZHP and its U.S.-based subsidiary, Prinston Pharmaceuticals, reported a potentially dangerous impurity in several batches of generic Valsartan to the Food and Drug Administration (FDA). By July 2018, the FDA had announced a voluntary recall of Valsartan products distributed by Prinston, Solco Healthcare, Major Pharmaceuticals, and Teva Pharmaceuticals Industries Ltd. Further investigations uncovered additional contaminated batches from other manufacturers.
The contamination involved chemicals such as N-nitroso dimethylamine (NDMA) and N-nitroso diethylamine (NDEA), both classified as probable human carcinogens by the Environmental Protection Agency (EPA). Subsequent investigations traced the contamination back to ZHP’s manufacturing process at its Chinese plant. By the end of 2018, millions of bottles of Valsartan and related drugs (including losartan and irbesartan) had been recalled in over 30 countries.
Why Are There Valsartan Lawsuits?
Key Allegations
Valsartan lawsuits have been filed against various manufacturers, alleging:
- Product Liability: Plaintiffs claim manufacturers failed to ensure the safety and purity of Valsartan products, leading to contamination.
- Negligence: Many lawsuits argue that pharmaceutical companies were negligent in their quality control processes, allowing harmful contaminants to enter the medication supply.
- Failure to Warn: Manufacturers allegedly failed to disclose the risks associated with contaminated Valsartan, a failure considered a “marketing defect.”
- Breach of Warranty: Plaintiffs assert that selling contaminated Valsartan breached the warranty of merchantability and fitness for a particular purpose.
Evidence and Implications
Government investigations and scientific studies confirm that significant amounts of generic Valsartan sold between 2015 and 2018 were contaminated. Some lawsuits allege manufacturers knowingly delayed reporting the contamination and prioritized profits over patient safety. If proven, these claims could result in substantial punitive damages.
Valsartan Lawsuits in MDL
Given the volume of lawsuits, Valsartan cases have been consolidated under multidistrict litigation (MDL) No. 2875 in the District of New Jersey. This MDL includes over 1,200 cases and is designed to streamline pre-trial processes for common questions of fact and law.
Bellwether Trials
Bellwether trials are a key feature of MDLs, where a few representative cases are tried first. Their outcomes can influence settlements for remaining cases. However, the Valsartan MDL has faced delays due to procedural disputes and a recent reassignment of the presiding judge.
Recent Developments
- Special Master Appointment: In June 2024, a special master was appointed to handle complex discovery issues.
- Discovery Challenges: Plaintiffs have requested sanctions against ZHP for failing to produce critical documents and a deposition of its CEO.
- Express Warranty Ruling: In March 2024, the MDL judge ruled that the defendants’ labeling of generic Valsartan constituted an “express warranty,” supporting breach-of-warranty claims.
Is There a Class Action Lawsuit?
Yes, one case in the MDL is a certified class action lawsuit with three classes of plaintiffs:
- Economic Damages: Individuals who purchased contaminated Valsartan.
- Medical Monitoring: Patients requiring ongoing cancer risk monitoring.
- Third-Party Payors: Insurers and agencies seeking reimbursement for claims.
This class action focuses on economic losses, while personal injury claims (e.g., cancer diagnoses) are pursued independently within the MDL.
Potential Compensation in Valsartan Lawsuits
Compensation in Valsartan cases varies depending on the damages sustained. Plaintiffs may be eligible for:
- Economic Damages: Medical expenses, lost wages, and related costs.
- Non-Economic Damages: Pain and suffering, emotional distress, and loss of quality of life.
- Punitive Damages: Awards designed to punish manufacturers for egregious conduct, such as knowingly distributing contaminated drugs.
While no Valsartan settlements have been reported yet, MDLs often result in global settlement agreements that simultaneously resolve large groups of cases.
The Importance of Legal Representation in Valsartan Cases
Navigating the complexities of pharmaceutical litigation requires experienced legal counsel. A skilled defective products attorney can:
- Determine your eligibility for compensation.
- Gather evidence and build a strong case.
- Negotiate settlements or advocate for you in court.
Given the stakes involved, consulting a pharmaceutical litigation attorney is essential for those affected by contaminated Valsartan.
Frequently Asked Questions
1. How much compensation can I receive from a Valsartan lawsuit?
Settlement amounts can vary significantly based on factors such as the severity of your injuries, the extent of medical expenses, lost wages, and the impact on your quality of life. In similar pharmaceutical cases, individual settlements have ranged from tens of thousands to millions of dollars. Although no Valsartan settlements have been finalized yet, the value of your claim will depend on your specific circumstances and the strength of your evidence.
2. Is Valsartan still being recalled?
Yes, the recalls of contaminated Valsartan began in 2018 and remain in effect for many generic products. These recalls primarily targeted Valsartan batches that contained APIs manufactured by ZHP and other suppliers with similar contamination risks. The FDA provides a searchable online recall database to help consumers identify affected products. Patients are advised to consult their healthcare provider to ensure their medication is safe.
3. Who is eligible to file a Valsartan lawsuit?
Eligibility to file a Valsartan lawsuit typically applies to individuals who:
- Took recalled Valsartan products.
- Experienced serious health issues such as cancer, believed to be linked to the contaminated medication.
- Incurred significant economic losses, such as out-of-pocket medical expenses or lost wages.
A consultation with an experienced pharmaceutical litigation attorney can help determine whether you qualify to join an ongoing class action or pursue an independent lawsuit.
4. What is the difference between a class action and an individual lawsuit?
A class action lawsuit consolidates claims from plaintiffs who share similar economic damages, such as paying for contaminated drugs or requiring medical monitoring. These cases aim to resolve issues collectively, often resulting in a single settlement or judgment shared among all class members.
An individual lawsuit, on the other hand, focuses on personal injuries, such as a cancer diagnosis, caused by contaminated Valsartan. These cases allow plaintiffs to seek compensation tailored to their unique circumstances, including economic and non-economic damages.
5. What should I do if I took Valsartan from a recalled batch?
If you have taken Valsartan from a recalled batch, acting quickly to protect your health and legal rights is crucial. Follow these steps:
- Consult Your Doctor: Discuss potential health risks and undergo any recommended medical evaluations, especially if you have been using Valsartan for an extended period.
- Preserve Evidence: Retain all medical records, prescription details, and any unused medication as evidence.
- Contact an Attorney: Contact a pharmaceutical litigation attorney to determine your eligibility to file a claim. They can guide you through the process and help you understand your legal options.
By taking these steps, you can safeguard your health while exploring potential avenues for compensation.